Abeona Reports Update from EB-101 Gene Therapy in Epidermolysis Bullosa at 21st Annual ASGCT Meeting

Go back to Abeona Reports Update from EB-101 Gene Therapy in Epidermolysis Bullosa at 21st Annual ASGCT Meeting
(NASDAQ: ABEO) Delayed: 5.82 +0.07 (1.22%)
Previous Close $5.75    52 Week High $9.44 
Open $5.68    52 Week Low $2.05 
Day High $5.87    P/E N/A 
Day Low $5.67    EPS $0.00 
Volume 466,306